PCSK9 Inhibitors Market Analysis 2034 – Competitive Landscape, Clinical Trials, Market ...

In April 2025, AstraZeneca announced that its experimental oral PCSK9 inhibitor, AZD0780, achieved a 50.7% reduction in LDL ...

Six months in 'climate hell': Relentless heat causes routine fainting episodes in textile ...

"Almost every day [in the hot season] in our factory, five to seven people faint. Five to seven people just fall down." ...

Trump slashed university funding. Here are 6 key drugs that relied on it.

Medications that prevent HIV, shrink tumors and treat seizures were invented with government funding. At research ...